BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33854679)

  • 1. A review of computed tomography patterns of metastatic breast cancer patients undergoing treatment at a private oncology centre in Ghana.
    Mensah YB; Edusa C; Nsaful J; Mensah NA
    Pan Afr Med J; 2021; 38():50. PubMed ID: 33854679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT.
    Pujara AC; Raad RA; Ponzo F; Wassong C; Babb JS; Moy L; Melsaether AN
    Breast J; 2016 May; 22(3):264-73. PubMed ID: 26843433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
    Morris PG; Ulaner GA; Eaton A; Fazio M; Jhaveri K; Patil S; Evangelista L; Park JY; Serna-Tamayo C; Howard J; Larson S; Hudis CA; McArthur HL; Jochelson MS
    Cancer; 2012 Nov; 118(22):5454-62. PubMed ID: 22517371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of preoperative staging chest computed tomography to detect asymptomatic lung and liver metastasis in patients with primary breast carcinoma.
    Kim H; Han W; Moon HG; Min J; Ahn SK; Kim TY; Im SA; Oh DY; Han SW; Chie EK; Ha SW; Noh DY
    Breast Cancer Res Treat; 2011 Apr; 126(3):637-41. PubMed ID: 21298335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiologic patterns of distant organ metastasis in advanced breast cancer patients: Prospective review of computed tomography images.
    Jimah BB; Amoako E; Ofori EO; Akakpo PK; Aniakwo LA; Ulzen-Appiah K; Imbeah EG; Morna MT; Koggoh P; Akligoh H; Tackie R; Manu A; Paemka L; Sarkodie BD; Offei AK; Hutchful D; Ngoi J; Bediako Y; Rahman GA
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1988. PubMed ID: 38351553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer?
    Neal CH; Daly CP; Nees AV; Helvie MA
    Radiology; 2010 Nov; 257(2):335-41. PubMed ID: 20807849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/CT in breast cancer staging is useful for evaluation of axillary lymph node and distant metastases.
    Davidson T; Shehade N; Nissan E; Sklair-Levy M; Ben-Haim S; Barshack I; Zippel D; Halevy A; Chikman B
    Surg Oncol; 2021 Sep; 38():101567. PubMed ID: 33866190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of staging Computed Tomography on detection of occult metastasis in asymptomatic breast cancer patients.
    Rajasooriyar C; Sritharan T; Chenthuran S; Indranath K; Surenthirakumaran R
    Cancer Rep (Hoboken); 2020 Jun; 3(3):e1247. PubMed ID: 32671979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [(18)FDG PET/CT imaging in primary breast lymphoma and breast cancer].
    Estrada-Sánchez G; Ochoa-Carrillo FJ; Altamirano-Ley J
    Cir Cir; 2008; 76(4):279-86. PubMed ID: 18778536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer.
    Eubank WB; Mankoff DA; Takasugi J; Vesselle H; Eary JF; Shanley TJ; Gralow JR; Charlop A; Ellis GK; Lindsley KL; Austin-Seymour MM; Funkhouser CP; Livingston RB
    J Clin Oncol; 2001 Aug; 19(15):3516-23. PubMed ID: 11481358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of computerised tomography findings in women with liver metastases from breast cancer.
    Mhlanga JC; Evans AE; Doyle S; James JJ; Cornford EJ; Balls G; Chan SY; Ellis I
    Breast; 2011 Oct; 20(5):455-9. PubMed ID: 21596564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.
    Riegger C; Koeninger A; Hartung V; Otterbach F; Kimmig R; Forsting M; Bockisch A; Antoch G; Heusner TA
    Acta Radiol; 2012 Dec; 53(10):1092-8. PubMed ID: 23002144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
    Thangarajah F; Vogel C; Pahmeyer C; Eichler C; Holtschmidt J; Ratiu D; Mallmann P; Malter W
    Anticancer Res; 2018 Oct; 38(10):6023-6026. PubMed ID: 30275235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.
    Yamamura J; Kamigaki S; Fujita J; Osato H; Manabe H; Tanaka Y; Shinzaki W; Hashimoto Y; Komoike Y
    BMC Cancer; 2021 Apr; 21(1):476. PubMed ID: 33926418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidetector-row computed tomography for the preoperative evaluation of axillary nodal status in patients with breast cancer.
    Ogasawara Y; Doihara H; Shiraiwa M; Ishihara S
    Surg Today; 2008; 38(2):104-8. PubMed ID: 18239865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Whole-Body (18)F FDG PET/MR Imaging and Whole-Body (18)F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer.
    Melsaether AN; Raad RA; Pujara AC; Ponzo FD; Pysarenko KM; Jhaveri K; Babb JS; Sigmund EE; Kim SG; Moy LA
    Radiology; 2016 Oct; 281(1):193-202. PubMed ID: 27023002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
    J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and patterns of metastatic disease in locally advanced inflammatory and non-inflammatory breast cancer.
    Mvere MZ; James JJ; Cornford EJ; Tennant SL; Evans AJ; Ellis IO; Chan SY
    Clin Oncol (R Coll Radiol); 2011 Nov; 23(9):608-12. PubMed ID: 21549581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Is the Clinical Importance of Incidental Findings on Staging CT Scans in Patients With Sarcoma?
    Mayo Z; Kennedy S; Gao Y; Miller BJ
    Clin Orthop Relat Res; 2019 Apr; 477(4):730-737. PubMed ID: 30601764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.